{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-013466","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2025-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.681371+00:00","generated_at":"2026-05-20T02:15:14.622684+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Enveric stockholders approve conditional reverse stock split to avoid Nasdaq delisting","bullets":["Stockholders authorized board to implement reverse stock split between 1:5 and 1:50 if Nasdaq issues bid price delisting determination before Jan 28, 2026.","Reverse stock split proposal passed with 881,471 votes for, 301,346 against, 23,681 abstentions.","All six director nominees elected; Michael D. Webb received 175,763 votes for, 155,118 withheld (875,617 broker non-votes).","Say-on-pay proposal passed with 253,560 votes for, 75,850 against, 1,471 abstentions.","Auditor ratification of CBIZ CPAs P.C. passed with 1,082,606 votes for, 115,857 against, 8,035 abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-013466","json":"https://secwatch.observer/filing/0001641172-25-013466.json","markdown":"https://secwatch.observer/filing/0001641172-25-013466.md","text":"https://secwatch.observer/filing/0001641172-25-013466.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000164117225013466/0001641172-25-013466-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000164117225013466/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T02:15:14.622684+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}